Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis
Open Access
- 18 April 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 714, 149967
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 19 references indexed in Scilit:
- Distinct Clinical Pathology and Microbiota in Chronic Rhinosinusitis With Nasal Polyps EndotypesThe Laryngoscope, 2020
- B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acidsNature Communications, 2020
- Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic RhinosinusitisThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Regulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrateJournal of Allergy and Clinical Immunology, 2018
- Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polypsImmunity, Inflammation and Disease, 2017
- Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitisClinical Immunology, 2016
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial MetabolitesCell, 2016
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkersJournal of Allergy and Clinical Immunology, 2016
- The Interleukin-33-p38 Kinase Axis Confers Memory T Helper 2 Cell Pathogenicity in the AirwayImmunity, 2015
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cellsNature, 2013